BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 6132414)

  • 1. Midazolam: dose-response studies of effectiveness and rebound insomnia.
    Kales A; Soldatos CR; Bixler EO; Goff PJ; Vela-Bueno A
    Pharmacology; 1983; 26(3):138-49. PubMed ID: 6132414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of midazolam on sleep of insomniacs.
    Vogel GW; Vogel F
    Br J Clin Pharmacol; 1983; 16 Suppl 1(Suppl 1):103S-108S. PubMed ID: 6138060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose-response studies of lormetazepam: efficacy, side effects, and rebound insomnia.
    Kales A; Bixler EO; Soldatos CR; Mitsky DJ; Kales JD
    J Clin Pharmacol; 1982; 22(11-12):520-30. PubMed ID: 6131080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative clinical studies with midazolam, oxazepam and placebo.
    Feldmeier C; Kapp W
    Br J Clin Pharmacol; 1983; 16 Suppl 1(Suppl 1):151S-155S. PubMed ID: 6138069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rebound insomnia and elimination half-life: assessment of individual subject response.
    Bixler EO; Kales JD; Kales A; Jacoby JA; Soldatos CR
    J Clin Pharmacol; 1985 Mar; 25(2):115-24. PubMed ID: 2859304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early morning insomnia with rapidly eliminated benzodiazepines.
    Kales A; Soldatos CR; Bixler EO; Kales JD
    Science; 1983 Apr; 220(4592):95-7. PubMed ID: 6131538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rebound insomnia: a critical review.
    Gillin JC; Spinweber CL; Johnson LC
    J Clin Psychopharmacol; 1989 Jun; 9(3):161-72. PubMed ID: 2567741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative study of midazolam and vesparax in moderate or severe insomnia in female surgical patients.
    Philipp E; Kapp W
    Br J Clin Pharmacol; 1983; 16 Suppl 1(Suppl 1):161S-165S. PubMed ID: 6138071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sleep laboratory study of lormetazepam in older insomniacs.
    Vogel GW
    Psychopharmacology Suppl; 1984; 1():69-78. PubMed ID: 6147842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of midazolam, flunitrazepam, and placebo against midwinter insomnia in northern Norway.
    Lingjaerde O; Bratlid T; Westby OC; Gordeladze JO
    Acta Psychiatr Scand; 1983 Feb; 67(2):118-29. PubMed ID: 6133412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sleep laboratory studies of hypnotic drugs: efficacy and withdrawal effects.
    Kales A; Kales JD
    J Clin Psychopharmacol; 1983 Apr; 3(2):140-50. PubMed ID: 6132933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of midazolam and temazepam on sleep and performance when administered in the middle of the night.
    Roth T; Hauri P; Zorick F; Sateia M; Roehrs T; Kipp J
    J Clin Psychopharmacol; 1985 Apr; 5(2):66-9. PubMed ID: 2859305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the efficacy and tolerance of orally administered midazolam as hypnotic agent compared with oxazepam in the treatment of insomnia of mild to moderate severity.
    Helcl I; Lupolover R; Buch JP; Amrein R
    Arzneimittelforschung; 1981; 31(12a):2284-7. PubMed ID: 6120705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quazepam, a new benzodiazepine hypnotic: intermediate-term sleep laboratory evaluation.
    Kales A; Scharf MB; Soldatos CR; Bixler EO; Bianchi SB; Schweitzer PK
    J Clin Pharmacol; 1980 Apr; 20(4):184-92. PubMed ID: 6103903
    [No Abstract]   [Full Text] [Related]  

  • 15. Midazolam and oxazepam in the treatment of insomnia in hospitalized patients.
    Gallais H; Casanova P; Fabregat H
    Br J Clin Pharmacol; 1983; 16 Suppl 1(Suppl 1):145S-149S. PubMed ID: 6138068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quazepam and temazepam: effects of short- and intermediate-term use and withdrawal.
    Kales A; Bixler EO; Soldatos CR; Vela-Bueno A; Jacoby JA; Kales JD
    Clin Pharmacol Ther; 1986 Mar; 39(3):345-52. PubMed ID: 2868823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sleep laboratory study of the effects of midazolam in insomniac patients.
    Monti JM; Debellis J; Gratadoux E; Alterwain P; Altier H; D'Angelo L
    Eur J Clin Pharmacol; 1982; 21(6):479-84. PubMed ID: 7075654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of efficacy and safety of midazolam administered orally in sleep disorders. A dose-finding study.
    Lupolover R; Buch JP
    Arzneimittelforschung; 1981; 31(12a):2281-3. PubMed ID: 6120704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative effectiveness of nine hypnotic drugs: sleep laboratory studies.
    Kales A; Bixler EO; Kales JD; Scharf MB
    J Clin Pharmacol; 1977 Apr; 17(4):207-13. PubMed ID: 321488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quazepam and flurazepam: long-term use and extended withdrawal.
    Kales A; Bixler EO; Soldatos CR; Vela-Bueno A; Jacoby J; Kales JD
    Clin Pharmacol Ther; 1982 Dec; 32(6):781-8. PubMed ID: 7140142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.